Valeant defends price hikes after Clinton remarks; shares jump

(Reuters) - Shares of Valeant Pharmaceuticals International Inc jumped 6 percent on Friday, after the company responded to criticism by Democratic presidential contender Hillary Clinton over price hikes for its migraine drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.